Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001127602-14-033835)

Filing Details

Accession Number:: 0001127602-14-033835
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-12-02 14:51:45
Reporting Period:: 2014-12-01

Filing Date:: 2014-12-02
Accepted Time:: 2014-12-02 14:51:45
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
794172	Meridian Bioscience Inc	VIVO	In Vitro & In Vivo Diagnostic Substances (2835)	310888197

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1224665	Susan Rolih	3471 River Hills Drive Cincinnati OH 45244	Evp, Reg & Quality Systems	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-12-01	15,750	$7.28	127,763	No	4	M	Direct
Common Stock	Disposition	2014-12-01	11,219	$16.46	116,544	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Options (Right to Buy)	Disposition	2014-12-01	15,750	$0.00	15,750	$7.28

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2014-12-07	No	4	M	Direct

Footnotes

Prices range from $16.42 per share to $16.52 per share. The reporting person undertakes to provide full pricing information if requested by the Securities and Exchange Commission, the issuer or a security holder of the issuer.
These options became fully vested in November 2008.